首页 › 基金 › Defilade Capital Management, L.P. › TYRA

Defilade Capital Management, L.P. 对 TYRA 的持仓历史

TYRA BIOSCIENCES INC COM · 医疗保健

Defilade Capital Management, L.P. 在 Q2 2026 的 13F 申报中披露持有 TYRA(TYRA BIOSCIENCES INC COM)376,870 股,市值约 US$12.0M,约占其申报组合的 1.61%,在其申报持仓中市值排名第 24 位。 Defilade Capital Management, L.P. 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)376.87K 股
申报持仓市值$12.04M
组合权重1.61%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Defilade Capital Management, L.P. 对 TYRA 的持仓演变

Defilade Capital Management, L.P. 于 Q2 2026 首次披露 TYRA 持仓:376,870 股(约 US$12.0M)。

逐季持仓明细

季度股数金额变化
Q2 2026 376.87K $12.04M 新进

关于 TYRA 与 13F 数据

TYRA(TYRA BIOSCIENCES INC COM)属于医疗保健行业。我们追踪的基金中还有 57 只申报持有 TYRA,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$389.6M), Alta Partners Management Company, L.P. (US$122.1M), Nextech Invest Ltd. (US$113.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TYRA 的基金

查看 TYRA 的全部基金持有人 →

常见问题

How long has Defilade Capital Management, L.P. held TYRA?

Defilade Capital Management, L.P. has disclosed TYRA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Defilade Capital Management, L.P.'s current position in TYRA?

As of Q2 2026, Defilade Capital Management, L.P. holds 376.87K shares of TYRA (TYRA BIOSCIENCES INC COM), valued at $12.04M, representing 1.61% of its reported portfolio and ranking #24.

Has Defilade Capital Management, L.P. been buying or selling TYRA?

In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. newly opened its position in TYRA.

Which other funds hold TYRA?

Other major institutional holders of TYRA include RA CAPITAL MANAGEMENT, L.P., Alta Partners Management Company, L.P., Nextech Invest Ltd., among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.